膜マイクロドメインにおける成長因子受容体の制御
スポンサーリンク
概要
著者
-
KABAYAMA Kazuya
Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutic
-
INOKUCHI Jin-ichi
Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutic
-
Kabayama Kazuya
Division Of Glycopathology Institute Of Molecular Biomembrane And Glycobiology Tohoku Pharmaceutical
-
Inokuchi Jin-ichi
Division Of Glycopathology And Crest Japan Science And Technology Agency Institute Of Molecular Biom
-
Inokuchi Jin-ichi
Division Of Glycopathology Institute Of Molecular Biomembranes And Glycobiology Tohoku Pharmaceutica
-
Kabayama Kazuya
Division Of Glycopathology Institute Of Molecular Biomembranes And Glycobiology Tohoku Pharmaceutica
関連論文
- GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
- Development of a New Inhibitor of Glucosylceramide Synthase^1
- 膜マイクロドメインにおける成長因子受容体の制御
- Physiopathological function of hematoside (GM3 ganglioside)
- Insulin Resistance as a Membrane Microdomain Disorder(Symposium Review)